Cabio Biotech (Wuhan) Co., Ltd. engages in the research, development, production, and sale of functional ingredients and bio-based products in China and internationally. The company offers polyunsaturated fatty acids, including arachidonic acid (ARA) and docosahexaenoic acid (DHA); terpenoids, such as beta (ß)-carotene and astaxanthin; and carbohydrates, such as N-acetylneuraminic acid and human milk oligosaccharides. Its products are used in human nutrition, including early life nutrition and dietary supplements; animal nutrition, such as economic animal and pet nutrition; personal care and cosmetics; and synthetic biology applications. The company also engages in the production of food additives and other food products; consulting services in bioengineering, environmental protection, healthcare, and food technologies; research, development, and sale of biological feed and feed additives; food wholesale; technology development; and venture capital activities. Cabio Biotech (Wuhan) Co., Ltd. was founded in 1999 and is based in Wuhan, the People's Republic of China.
Frequently asked questions
What sector does Cabio Biotech Wuhan Co Ltd (688089) operate in?
Cabio Biotech Wuhan Co Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Cabio Biotech Wuhan Co Ltd (688089) current stock price?
As of the latest data, Cabio Biotech Wuhan Co Ltd stock price is CN¥8.59, with a previous close of CN¥8.59.
What is Cabio Biotech Wuhan Co Ltd (688089) current market capitalization?
Cabio Biotech Wuhan Co Ltd market cap is approximately 1.43 billion.
What is Cabio Biotech Wuhan Co Ltd (688089) Earnings Per Share (EPS)?
The trailing EPS is -CN¥0.38.
Does Cabio Biotech Wuhan Co Ltd (688089) pay dividends?
No. Cabio Biotech Wuhan Co Ltd does not pay a dividend.
What is Cabio Biotech Wuhan Co Ltd (688089) beta (volatility) score?
Cabio Biotech Wuhan Co Ltd has a beta of 0.409, indicating lower volatility than the overall market.